Maximilian Pistor

5PUBLICATIONS

12CO-AUTHORS

Medical infection agents (incl. prions)Predictive and prognostic markersMotor controlAutoimmunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 08, 2026

Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness Estimates.

|Oct 14, 2022

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.

Maximilian Pistor, Robert Hoepner, Andreas G F Hoepner

|Jan 21, 2022

Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.

Maximilian Pistor, Helly Hammer, Anke Salmen

|Jul 21, 2021

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Maximilian Pistor, Andreas G F Hoepner, Yanan Lin

|Sep 26, 2020

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.

Maud Bagnoud, Myriam Briner, Jana Remlinger

Pageof 1

Frequent Collaborators

Anke Salmen

Robert Hoepner

Helly Hammer

Christoph Friedli

Timo Blattner

David Romascano

Richard McKinley

Michael Rebsamen

Roland Wiest

Piotr Radojewski

Frequent Collaborators

Anke Salmen

Robert Hoepner

Helly Hammer

Christoph Friedli